140 related articles for article (PubMed ID: 34586470)
1. Assessment of cervical vascularization density in patients with locally advanced squamous cell cervical carcinoma evaluated in colour Doppler and power Doppler functions.
Tomalczyk A; Tomasik B; Fijuth J; Moszynska-Zielinska M; Gottwald L
Arch Gynecol Obstet; 2022 Apr; 305(4):955-961. PubMed ID: 34586470
[TBL] [Abstract][Full Text] [Related]
2. Assessment of cervical volume and spectral Doppler parameters in tumour dominant vessel of patients with locally advanced squamous cell cervical carcinoma.
Tomalczyk A; Tomasik B; Fijuth J; Moszynska-Zielinska M; Gottwald L
J Obstet Gynaecol; 2021 Oct; 41(7):1116-1120. PubMed ID: 33427547
[TBL] [Abstract][Full Text] [Related]
3. Clinical significance of CD34, podoplanin and Ki-67 expression in patients with locally advanced squamous cell cervical carcinoma.
Kubik S; Jesionek-Kupnicka D; Stawiski K; Fijuth J; Moszynska-Zielinska M; Kuncman L; Pajdzinski M; Gottwald L
J Obstet Gynaecol; 2022 Aug; 42(6):2248-2254. PubMed ID: 35264072
[TBL] [Abstract][Full Text] [Related]
4. Power Doppler vascularity index for predicting the response of neoadjuvant chemotherapy in cervical carcinoma.
Chen CA; Cheng WF; Lee CN; Su YN; Hsieh CY; Hsieh FJ
Acta Obstet Gynecol Scand; 2004 Jun; 83(6):591-7. PubMed ID: 15144343
[TBL] [Abstract][Full Text] [Related]
5. Three-Dimensional Power Doppler Ultrasound for Predicting Response and Local Recurrence After Concomitant Chemoradiation Therapy for Locally Advanced Carcinoma of the Cervix.
Alcazar JL; Arribas S; Martinez-Monge R; Jurado M
Int J Gynecol Cancer; 2016 Mar; 26(3):534-8. PubMed ID: 26745701
[TBL] [Abstract][Full Text] [Related]
6. Impact of Treatment Time on Chemoradiotherapy in Locally Advanced Cervical Carcinoma.
Pathy S; Kumar L; Pandey RM; Upadhyay A; Roy S; Dadhwal V; Madan R; Chander S
Asian Pac J Cancer Prev; 2015; 16(12):5075-9. PubMed ID: 26163644
[TBL] [Abstract][Full Text] [Related]
7. The prognostic factors for locally advanced cervical cancer patients treated by intensity-modulated radiation therapy with concurrent chemotherapy.
Chen CC; Wang L; Lin JC; Jan JS
J Formos Med Assoc; 2015 Mar; 114(3):231-7. PubMed ID: 25777974
[TBL] [Abstract][Full Text] [Related]
8. PRospective Imaging of CErvical cancer and neoadjuvant treatment (PRICE) study: role of ultrasound to predict partial response in locally advanced cervical cancer patients undergoing chemoradiation and radical surgery.
Testa AC; Ferrandina G; Moro F; Pasciuto T; Moruzzi MC; De Blasis I; Mascilini F; Foti E; Autorino R; Collarino A; Gui B; Zannoni GF; Gambacorta MA; Valentini AL; Rufini V; Scambia G
Ultrasound Obstet Gynecol; 2018 May; 51(5):684-695. PubMed ID: 28620930
[TBL] [Abstract][Full Text] [Related]
9. Association of color Doppler vascularity index and microvessel density with survival in patients with gastric cancer.
Chen CN; Cheng YM; Lin MT; Hsieh FJ; Lee PH; Chang KJ
Ann Surg; 2002 Apr; 235(4):512-8. PubMed ID: 11923607
[TBL] [Abstract][Full Text] [Related]
10. Endorectal power Doppler ultrasonography is a reliable method for evaluation of rectal cancer angiogenesis.
Tankova L; Nakov R; Stoilov G; Gegova A; Nakov V; Gerova V; Terziev I; Kovatchki D
Eur Rev Med Pharmacol Sci; 2019 Feb; 23(4):1661-1667. PubMed ID: 30840290
[TBL] [Abstract][Full Text] [Related]
11. Doppler Ultrasound Flow Evaluation of the Uterine Arteries Significantly Correlates with Tumor Size in Cervical Cancer Patients.
Bolla D; In-Albon S; Papadia A; Di Naro E; Gasparri ML; Mueller MM; Raio L
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S959-63. PubMed ID: 26036189
[TBL] [Abstract][Full Text] [Related]
12. Effectiveness of Image-guided Brachytherapy in Patients With Locally Advanced Cervical Squamous Cell Carcinoma Receiving Concurrent Chemoradiotherapy.
Chen SW; Liang JA; Hung YC; Yeh LS; Chang WC; Lin WC; Chang YY
Anticancer Res; 2019 Jun; 39(6):3015-3024. PubMed ID: 31177143
[TBL] [Abstract][Full Text] [Related]
13. The assessment of spectral Doppler parameters in uterine arteries of patients with locally advanced squamous cell cervical cancer.
Tomalczyk A; Tomasik B; Moszynska-Zielinska M; Fijuth J; Spych M; Gottwald L
Ginekol Pol; 2019; 90(11):622-627. PubMed ID: 31802461
[TBL] [Abstract][Full Text] [Related]
14. Comparison of treatment outcomes between squamous cell carcinoma and adenocarcinoma of cervix after definitive radiotherapy or concurrent chemoradiotherapy.
Hu K; Wang W; Liu X; Meng Q; Zhang F
Radiat Oncol; 2018 Dec; 13(1):249. PubMed ID: 30558636
[TBL] [Abstract][Full Text] [Related]
15. Combination external beam radiotherapy and high-dose-rate intracavitary brachytherapy for uterine cervical cancer: analysis of dose and fractionation schedule.
Toita T; Kakinohana Y; Ogawa K; Adachi G; Moromizato H; Nagai Y; Maehama T; Sakumoto K; Kanazawa K; Murayama S
Int J Radiat Oncol Biol Phys; 2003 Aug; 56(5):1344-53. PubMed ID: 12873679
[TBL] [Abstract][Full Text] [Related]
16. The Utility of Pretreatment and Posttreatment Lymphopenia in Cervical Squamous Cell Carcinoma Patients Treated With Definitive Chemoradiotherapy.
Onal C; Yildirim BA; Guler OC; Mertsoylu H
Int J Gynecol Cancer; 2018 Oct; 28(8):1553-1559. PubMed ID: 30247248
[TBL] [Abstract][Full Text] [Related]
17. PRospective Imaging of CErvical cancer and neoadjuvant treatment (PRICE) study: role of ultrasound to assess residual tumor in locally advanced cervical cancer patients undergoing chemoradiation and radical surgery.
Testa AC; Moro F; Pasciuto T; Moruzzi MC; Di Legge A; Fuoco G; Autorino R; Collarino A; Gui B; Zannoni GF; Gambacorta A; Miccò M; Rufini V; Scambia G; Ferrandina G
Ultrasound Obstet Gynecol; 2018 Jul; 52(1):110-118. PubMed ID: 29119649
[TBL] [Abstract][Full Text] [Related]
18. High dose rate versus low dose rate intracavity brachytherapy for locally advanced uterine cervix cancer.
Wang X; Liu R; Ma B; Yang K; Tian J; Jiang L; Bai ZG; Hao XY; Wang J; Li J; Sun SL; Yin H
Cochrane Database Syst Rev; 2010 Jul; (7):CD007563. PubMed ID: 20614461
[TBL] [Abstract][Full Text] [Related]
19. Concurrent chemoradiotherapy incorporating high-dose rate brachytherapy for locally advanced cervical carcinoma: survival outcomes, patterns of failure, and prognostic factors.
Teh J; Yap SP; Tham I; Sethi VK; Chua EJ; Yeo R; Ho TH; Tay EH; Chia YN; Soh LT; Khoo-Tan HS
Int J Gynecol Cancer; 2010 Apr; 20(3):428-33. PubMed ID: 20375809
[TBL] [Abstract][Full Text] [Related]
20. Cisplatin Chemoradiotherapy vs Radiotherapy in FIGO Stage IIIB Squamous Cell Carcinoma of the Uterine Cervix: A Randomized Clinical Trial.
Shrivastava S; Mahantshetty U; Engineer R; Chopra S; Hawaldar R; Hande V; Kerkar RA; Maheshwari A; Shylasree TS; Ghosh J; Bajpai J; Gurram L; Gulia S; Gupta S;
JAMA Oncol; 2018 Apr; 4(4):506-513. PubMed ID: 29423520
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
